Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK-2250665A is an interleukin-2-inducible T-cell kinase (Itk) inhibitor with a binding affinity of pKi = 9.2, GSK-2250665A demonstrates significant selectivity for Itk over Aurora B kinase and Bruton's tyrosine kinase (Btk), with pIC50 values of 6.4 and 6.5 respectively, while also showing limited activity against other kinases, and GSK-2250665A inhibits interferon-gamma (IFNγ) production in peripheral blood mononuclear cells (PBMCs), establishing it as a highly selective chemical probe for T-cell receptor signaling research and immune modulation studies.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $599 | In Stock |
Description | GSK-2250665A is an interleukin-2-inducible T-cell kinase (Itk) inhibitor with a binding affinity of pKi = 9.2, GSK-2250665A demonstrates significant selectivity for Itk over Aurora B kinase and Bruton's tyrosine kinase (Btk), with pIC50 values of 6.4 and 6.5 respectively, while also showing limited activity against other kinases, and GSK-2250665A inhibits interferon-gamma (IFNγ) production in peripheral blood mononuclear cells (PBMCs), establishing it as a highly selective chemical probe for T-cell receptor signaling research and immune modulation studies. |
Targets&IC50 | Itk:9.2 (pKi) |
In vitro | The pIC50 value of GSK-2250665A (Compound 13) for inhibiting IFNγ production in PBMCs is 7.3, as measured in a cell-based assay [1]. |
Synonyms | GSK2250665A |
Molecular Weight | 459.61 |
Formula | C26H29N5OS |
Cas No. | 1246030-96-5 |
Smiles | N(C=1SC=2C(N1)=CC=C(CC)C2)C3=NC(N[C@H]4CC[C@H](O)CC4)=NC(CC5=CC=CC=C5)=C3 |
Relative Density. | 1.313 g/cm3 (Predicted) |
Color | White |
Appearance | Lyophilized powder |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.